IDENIX PHARMACEUTICALS INC - FORM 10-K - EX-23.1 - EX-23.1 CONSENT OF PRICEWATERHOUSECOOPERS LLP - March 7, 2011

Attached files

file filename
10-K - FORM 10-K - IDENIX PHARMACEUTICALS INCc13549e10vk.htm
EX-31.1 - EX-31.1 CEO CERT SECTION 302 - IDENIX PHARMACEUTICALS INCc13549exv31w1.htm
EX-32.2 - EX-32.2 CFO CERT SECTION 906 - IDENIX PHARMACEUTICALS INCc13549exv32w2.htm
EX-21.1 - EXHIBIT 21.1 - IDENIX PHARMACEUTICALS INCc13549exv21w1.htm
EX-32.1 - EX-32.1 CEO CERT SECTION 906 - IDENIX PHARMACEUTICALS INCc13549exv32w1.htm
EX-10.62 - EX-10.62 EMPLOYMENT LETTER, DATED NOVEMBER 30, 2010, BY AND BETWEEN THE REGISTRANT AND MARIA STAHL - IDENIX PHARMACEUTICALS INCc13549exv10w62.htm
EX-10.61 - EX-10.61 EMPLOYMENT LETTER, DATED DECEMBER 9, 2010, BY AND BETWEEN THE REGISTRANT AND DAVID N. STANDRING, PH.D. - IDENIX PHARMACEUTICALS INCc13549exv10w61.htm
EX-31.2 - EX-31.2 CFO CERT SECTION 302 - IDENIX PHARMACEUTICALS INCc13549exv31w2.htm
EX-10.60 - EX-10.60 EMPLOYMENT LETTER, DATED DECEMBER 8, 2010, BY AND BETWEEN THE REGISTRANT AND DOUGLAS L. MAYERS, M.D. - IDENIX PHARMACEUTICALS INCc13549exv10w60.htm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-118341, 333-128882, 333-143620 and 333-167330) and Form S-3 (File Nos. 333-127710, 333-129213, 333-153471 and 333-159716) of Idenix Pharmaceuticals, Inc. of our report dated March 7, 2011 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 7, 2011

 

 

Stock widget

Investing forum

IDENIX PHARMACEUTICALS INC Reports